XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.25.2

SEGMENT INFORMATION (Tables) | 6 Months Ended
--- | ---
Jun. 27, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information | Segment results for the three-month period ended June 27, 2025 are shown below ($ in millions):
| Total |  | Intelligent Operating Solutions |  | Precision Technologies |  | Advanced Healthcare Solutions |  | Unallocated Corporate Costs and Other
Sales | $ | 1,518.8 |  |  | $ | 675.7 |  |  | $ | 523.6 |  |  | $ | 319.5 |  |  | $ | — |
Cost of sales | (623.1) |  |  | (231.8) |  |  | (261.3) |  |  | (130.0) |  |  | — |
Gross profit | 895.7 |  |  | 443.9 |  |  | 262.3 |  |  | 189.5 |  |  | — |
Operating expenses (a) | (673.5) |  |  | (277.2) |  |  | (169.1) |  |  | (150.4) |  |  | (76.8) |
Operating profit (loss) | 222.2 |  |  | 166.7 |  |  | 93.2 |  |  | 39.1 |  |  | (76.8) |
Non-operating income (expense), net |  |  |  |  |  |  |  |  |
Interest expense, net | (32.1) |  |  | — |  |  | — |  |  | — |  |  | (32.1) |
Other non-operating expense, net | 1.9 |  |  | — |  |  | — |  |  | — |  |  | 1.9 |
Earnings before income taxes | $ | 192.0 |  |  | $ | 166.7 |  |  | $ | 93.2 |  |  | $ | 39.1 |  |  | $ | (107.0) |
Depreciation and amortization expenses | $ | (137.8) |  |  | $ | (58.4) |  |  | $ | (28.7) |  |  | $ | (50.4) |  |  | $ | (0.3) |
Capital expenditure | $ | (36.7) |  |  | $ | (20.1) |  |  | $ | (11.6) |  |  | $ | (4.9) |  |  | $ | (0.1) |
(a) Unallocated Corporate Costs and Other included $41 million of Separation-related costs. Refer to Note 2 for further detail.
Segment results for the three-month period ended June 28, 2024 are shown below ($ in millions):
| Total |  | Intelligent Operating Solutions |  | Precision Technologies |  | Advanced Healthcare Solutions |  | Unallocated Corporate Costs and Other
Sales | $ | 1,552.4 |  |  | $ | 677.0 |  |  | $ | 551.8 |  |  | $ | 323.6 |  |  | $ | — |
Cost of sales | (624.1) |  |  | (221.7) |  |  | (266.3) |  |  | (136.1) |  |  | — |
Gross profit | 928.3 |  |  | 455.3 |  |  | 285.5 |  |  | 187.5 |  |  | — |
Operating expenses | (626.5) |  |  | (282.1) |  |  | (170.2) |  |  | (147.3) |  |  | (26.9) |
Operating profit (loss) | 301.8 |  |  | 173.2 |  |  | 115.3 |  |  | 40.2 |  |  | (26.9) |
Non-operating income (expense), net |  |  |  |  |  |  |  |  |
Interest expense, net | (38.7) |  |  | — |  |  | — |  |  | — |  |  | (38.7) |
Loss from divestiture (a) | (25.6) |  |  | — |  |  | — |  |  | — |  |  | (25.6) |
Other non-operating expense, net | (8.8) |  |  | — |  |  | — |  |  | — |  |  | (8.8) |
Earnings before income taxes | $ | 228.7 |  |  | $ | 173.2 |  |  | $ | 115.3 |  |  | $ | 40.2 |  |  | $ | (100.0) |
Depreciation and amortization expenses | $ | (136.5) |  |  | $ | (57.1) |  |  | $ | (28.8) |  |  | $ | (50.4) |  |  | $ | (0.2) |
Capital expenditure | $ | (29.2) |  |  | $ | (14.9) |  |  | $ | (9.6) |  |  | $ | (3.1) |  |  | $ | (1.6) |
(a) Refer to Note 1 for further detail on Loss from divestiture.
Segment results for the six-month period ended June 27, 2025 are shown below ($ in millions):
| Total |  | Intelligent Operating Solutions |  | Precision Technologies |  | Advanced Healthcare Solutions |  | Unallocated Corporate Costs and Other
Sales | $ | 2,993.0 |  |  | $ | 1,347.1 |  |  | $ | 1,024.2 |  |  | $ | 621.7 |  |  | $ | — |
Cost of sales | (1,216.4) |  |  | (455.0) |  |  | (507.3) |  |  | (254.1) |  |  | — |
Gross profit | 1,776.6 |  |  | 892.1 |  |  | 516.9 |  |  | 367.6 |  |  | — |
Operating expenses (a) | (1,320.8) |  |  | (551.7) |  |  | (336.4) |  |  | (302.2) |  |  | (130.5) |
Operating profit (loss) | 455.8 |  |  | 340.4 |  |  | 180.5 |  |  | 65.4 |  |  | (130.5) |
Non-operating income (expense), net |  |  |  |  |  |  |  |  |
Interest expense, net | (64.1) |  |  | — |  |  | — |  |  | — |  |  | (64.1) |
Other non-operating expense, net | 1.7 |  |  | — |  |  | — |  |  | — |  |  | 1.7 |
Earnings before income taxes | $ | 393.4 |  |  | $ | 340.4 |  |  | $ | 180.5 |  |  | $ | 65.4 |  |  | $ | (192.9) |
Depreciation and amortization expenses | $ | (272.7) |  |  | $ | (116.3) |  |  | $ | (55.9) |  |  | $ | (99.9) |  |  | $ | (0.6) |
Capital expenditure | $ | (63.4) |  |  | $ | (37.0) |  |  | $ | (17.2) |  |  | $ | (8.9) |  |  | $ | (0.3) |
(a) Unallocated Corporate Costs and Other included $64 million of Separation-related costs. Refer to Note 2 for further detail.
Segment results for the six-month period ended June 28, 2024 are shown below ($ in millions):
| Total |  | Intelligent Operating Solutions |  | Precision Technologies |  | Advanced Healthcare Solutions |  | Unallocated Corporate Costs and Other
Sales | $ | 3,076.9 |  |  | $ | 1,342.7 |  |  | $ | 1,110.8 |  |  | $ | 623.4 |  |  | $ | — |
Cost of sales | (1,244.4) |  |  | (444.1) |  |  | (539.0) |  |  | (261.3) |  |  | — |
Gross profit | 1,832.5 |  |  | 898.6 |  |  | 571.8 |  |  | 362.1 |  |  | — |
Operating expenses | (1,291.6) |  |  | (561.3) |  |  | (370.5) |  |  | (294.4) |  |  | (65.4) |
Gain on sale of property (a) | 63.1 |  |  | — |  |  | 63.1 |  |  | — |  |  | — |
Operating profit (loss) | 604.0 |  |  | 337.3 |  |  | 264.4 |  |  | 67.7 |  |  | (65.4) |
Non-operating income (expense), net |  |  |  |  |  |  |  |  |
Interest expense, net | (82.7) |  |  | — |  |  | — |  |  | — |  |  | (82.7) |
Loss from divestiture (a) | (25.6) |  |  | — |  |  | — |  |  | — |  |  | (25.6) |
Other non-operating expense, net | (33.0) |  |  | — |  |  | — |  |  | — |  |  | (33.0) |
Earnings before income taxes | $ | 462.7 |  |  | $ | 337.3 |  |  | $ | 264.4 |  |  | $ | 67.7 |  |  | $ | (206.7) |
Depreciation and amortization expenses | $ | (273.3) |  |  | $ | (114.4) |  |  | $ | (58.2) |  |  | $ | (100.5) |  |  | $ | (0.2) |
Capital expenditure | $ | (55.6) |  |  | $ | (33.6) |  |  | $ | (13.7) |  |  | $ | (5.8) |  |  | $ | (2.5) |
(a) Refer to Note 1 for further detail on Gain on sale of property and Loss from divestiture.
Segment Assets:
| As of
($ in millions) | June 27, 2025 |  | December 31, 2024 |  |
Intelligent Operating Solutions | $ | 6,343.2 |  |  | $ | 6,320.1 |  |  |
Precision Technologies | 4,947.6 |  |  | 4,691.9 |  |  |
Advanced Healthcare Solutions | 4,947.1 |  |  | 5,008.6 |  |  |
Total segment assets | 16,237.9 |  |  | 16,020.6 |  |  |
Other (a) | 2,006.3 |  |  | 995.5 |  |  |
Total assets | $ | 18,244.2 |  |  | $ | 17,016.1 |  |  |
(a) Other represents corporate assets which consist primarily of cash, property, plant, and equipment, and net deferred income tax assets. |  |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration